Symbol="ABOS"
AssetType="Common Stock"
Name="Acumen Pharmaceuticals Inc"
Description="Acumen Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, is dedicated to developing therapies for the treatment of Alzheimer's disease and other neurodegenerative diseases. The company is headquartered in Charlottesville, Virginia."
CIK="1576885"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)"
Address="427 PARK ST., CHARLOTTESVILLE, VA, US"
FiscalYearEnd="December"
LatestQuarter="2023-03-31"
MarketCapitalization="207587000"
EBITDA="-49124000"
PERatio="None"
PEGRatio="None"
BookValue="4.365"
DividendPerShare="0"
DividendYield="0"
EPS="-1.15"
RevenuePerShareTTM="0.033"
ProfitMargin="0"
OperatingMarginTTM="0"
ReturnOnAssetsTTM="-0.151"
ReturnOnEquityTTM="-0.228"
RevenueTTM="329000"
GrossProfitTTM="-32361000"
DilutedEPSTTM="-1.15"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="0"
AnalystTargetPrice="14.57"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="538.78"
PriceToBookRatio="1.199"
EVToRevenue="89.67"
EVToEBITDA="-0.908"
Beta="-1.464"
num_52WeekHigh="10.97"
num_52WeekLow="3.52"
num_50DayMovingAverage="5.11"
num_200DayMovingAverage="5.61"
SharesOutstanding="41025100"
DividendDate="None"
ExDividendDate="None"
symbol="ABOS"
open="5.06"
high="5.12"
low="4.95"
price="5.06"
volume="95750.00"
latest_trading_day="2023-07-07"
previous_close="5.05"
change="0.01"
change_percent="0.1980%"
aroon_positive_momentum_days="57"
aroon_negative_momentum_days="0"
trend_strength="Absent or Weak Trend"
buying_signal="Weak Buy Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="57"
Volume_recent_avg="154892"
Change_recent_avg="-0.03"
Delta_recent_avg="0.42"
Variance_recent_avg="0.21"
Change_ratio_recent_avg="-0.72"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="positive"
Aroon_change="FALSE"
Aroon_momentum_positive="57"
Aroon_momentum_negative="43"
image_negative_thumbnail_id_1="1096"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0129.jpeg"
image_negative_thumbnail_id_2="1092"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0125.jpeg"
image_neutral_thumbnail_id_1="542"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0057.jpeg"
image_neutral_thumbnail_id_2="583"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0016.jpeg"
image_positive_thumbnail_id_1="1016"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0178.jpeg"
image_positive_thumbnail_id_2="976"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0138.jpeg"
image_professor_thumbnail_id_1="1199"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0033.jpeg"
image_professor_thumbnail_id_2="1190"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0024.jpeg"
